DANIEL ESMAILI, M.D.
Ophthalmology Physician · BEVERLY HILLS, CA
Individual Active NPI 1629279864
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,050 | 34,231 | $10,956,526 | $3,768,307 | $2,941,727 |
| 2023 | 1,010 | 22,732 | $10,292,631 | $3,602,890 | $2,823,406 |
| 2022 | 949 | 14,542 | $9,096,106 | $3,161,636 | $2,469,761 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,720 | $34 | $27 |
| 92134 | Imaging of retina | 3,244 | $44 | $34 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2,484 | $229 | $179 |
| 67028 | Injection of drug into eye | 2,023 | $128 | $100 |
| 92014 | Established patient complete exam of visual system | 1,727 | $138 | $99 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,515 | $147 | $116 |
| J0178 | Injection, aflibercept, 1 mg | 1,457 | $829 | $654 |
| 92012 | Established patient problem focused exam of visual system | 1,089 | $99 | $77 |
| J9035 | Injection, bevacizumab, 10 mg | 407 | $72 | $57 |
| J0177 | Injection, aflibercept hd, 1 mg | 296 | $332 | $265 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 219 | $16 | $11 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 190 | $26 | $17 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A91049 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1457652851
- NPI 1225047509
- NPI 1124182662
- NPI 1326092529
- NPI 1306957329
- NPI 1669583746
- NPI 1245740711
- NPI 1952562159
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.